Presentation TCT 2016 Severe AS and Extreme Co-morbidities (Futile Patient?) Presenter: Neal S. Kleiman, Patrick T. O'Gara, Suzanne V. Arnold October 30, 2016
Presentation TCT 2016 Management of Failing Aortic Bioprosthesis Presenter: Neal S. Kleiman, Patrick T. O'Gara, Danny Dvir October 30, 2016
Presentation TCT 2016 TAVR in Patients With Atrial Fibrillation Presenter: Neal S. Kleiman, Patrick T. O'Gara, Fabian Nietlispach October 30, 2016
Presentation TCT 2016 My Rosy Prophecy: What Will the Specialty of Mitral Valve Therapeutics Look Like in 10 Years? Presenter: James S. Gammie, James B. Hermiller Jr., Alec S. Vahanian October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Surgical Mitral Valve Repair Or Replacement Via A Minimally Invasive Approach Will Be The Gold Standard! Presenter: James S. Gammie, James B. Hermiller Jr., Steven F. Bolling October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? No, The Bar Is Too High Transcatheter Mitral Repair Will Always Be Safer And Nearly As Effective! Presenter: James S. Gammie, James B. Hermiller Jr., Ted Feldman October 30, 2016
Presentation TCT 2016 Second Debate: In 10 Years, How Will We Treat Most Patients With Secondary MR? Transcatheter MV Replacement Will Become Standard Of Care For Secondary MR! Presenter: James S. Gammie, James B. Hermiller Jr., Stephan Windecker October 30, 2016
Presentation TCT 2016 First Debate: Should The Low Surgical Risk Patient With Degenerative MR Be Offered Mitraclip? Absolutely Not - In No Universe Would That Be Considered Acceptable Care! Presenter: James S. Gammie, James B. Hermiller Jr., Alfredo Trento October 30, 2016
Presentation TCT 2016 Personalized Medicine Where Are We in 2016? Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy October 30, 2016
Presentation TCT 2016 First Debate: Should the Low Surgical Risk Patient With Degenerative MR Be Offered Mitraclip? Absolutely! - As Long as He Receives Truly Informed Consent by A Heart Team! Presenter: James S. Gammie, James B. Hermiller Jr., Brian K. Whisenant October 30, 2016
Presentation TCT 2016 Anti-inflammatory Therapies for Atherosclerosis Presenter: Robert A. Harrington, A. Michael Lincoff, Jean-Claude Tardif October 30, 2016
Presentation TCT 2016 Heart Failure Advances (Ivabradine, ARNI, and More) Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy October 30, 2016
Presentation TCT 2016 Diabetes Advances (SGLT-2, GLP-1, DPP4) Presenter: Robert A. Harrington, A. Michael Lincoff, Norman E. Lepor October 30, 2016
Presentation TCT 2016 Transcatheter Valve Replacement for Ring Annuloplasty Failures: Valve-in-Ring Results Presenter: Michael J. Mack, Francesco Maisano, Dominique Himbert October 30, 2016
Presentation TCT 2016 Transcatheter Valve Replacement for Mitral Bioprosthetic Valve Failures: Multicenter VIVID Registry Results Presenter: Michael J. Mack, Francesco Maisano, Danny Dvir October 30, 2016
Presentation TCT 2016 Surgically Implanted Sapien Valve in Mitral Annular Calcium: SITRAL Trial Presenter: Michael J. Mack, Francesco Maisano, Robert L. Smith October 30, 2016
Presentation TCT 2016 Transcatheter Valve Replacement for Native Mitral Stenosis: Lessons from the International Registry Presenter: Michael J. Mack, Francesco Maisano, Mayra Guerrero October 30, 2016
Presentation TCT 2016 Reversal of Chronic Anticoagulation: When, What, and How Effective? Presenter: Paul A. Gurbel, James A. Reiffel October 30, 2016
Presentation TCT 2016 CT Imaging to Guide Selection and Treatment for Transcatheter MV Replacement: Lessons Learned From Early Feasibility Studies Presenter: Michael J. Mack, Francesco Maisano, Jonathon A. Leipsic October 30, 2016
Presentation TCT 2016 Chronic Oral Anticoagulants: Limitations, Use Recommendations, and Investigational Agents Presenter: Paul A. Gurbel, Christopher B. Granger October 30, 2016